An update on CancerSEEK and its future potential: an interview with Cristian Tomasetti

We recently had the opportunity to interview Cristian Tomasetti (John Hopkins University, MD, US) about his work on the CancerSEEK project. He provides an important insight into how the CancerSEEK technology works and its future as a clinical tool, as well as highlighting the ongoing challenges the team are working on to ensure its success. Tomasetti also discusses ASCO and his involvement in the DYNAMIC project, which uses circulating tumor DNA (ctDNA) as a real time marker for analysing the risk of Stage III colon cancer.How does the CancerSEEK technology works? CancerSEEK currently uses circulating tumor DNA (ctDNA) and protein...